Renerva, LLC
Investigational surgical device for enhancing nerve regeneration and healing after nerve injury
- Sector
- Medtech
- Headquarters
- Pittsburgh, PA
- Founded
- 2017
- Latest Form D
- $325K, Sep 2025
- Total capital
- $4.2M
- Federal grants
- $3.3M
- 6 awards · 2019–2025
- Rank in peer group#13 of 36
- Private capital raised
- $942K
- 3 Form D · last Sep 2025
- 13 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 10 pending · first 2025
- Rank in peer group#9 of 36
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$325K
- Federal grantHealth and Human S · Phase I · PNM-CAP: A novel nerve cap to prevent painful neuroma formation in peripheral nerve injuries and amputations$500K
- Federal grantHealth and Human S · Phase I · Restoration of Neuromuscular Function Following Critical Nerve Gap Injuries$500K
- Offering registeredForm D · SEC · 2nd filing$1.5M
- Federal grantHealth and Human S · Phase I · Restoration of Muscular Function Following Direct Muscle Neurotization$495K
- Federal grantNSF · Phase II · SBIR Phase II:A novel peripheral nerve matrix platform for severe acute peripheral nerve injuries$1.3M
- Federal grantHealth and Human S · Phase I · Altering the injury microenvironment with a macrophage and Schwann Cell recruiting extracellular matrix-based hydrogel to improve laryngeal nerve injury recovery$274K
- Private capital raisedForm D · SEC · 1st filing$617K
Show 1 earlier federal award
- Federal grantNSF · Phase I · SBIR Phase I: Development of a Peripheral Nerve Matrix Conduit to Enable Nerve Regeneration$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grants#13 · top 36%
- Granted patents#9 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Lorenzo SolettiResearcherExecutive Officer, Director, PromoterLinked by 1 patent · $3.3M in grants as PI
- Bryan N. BrownExecutive OfficerNamed in SEC Form D filings
- J. Christopher FlahertyExecutive OfficerNamed in SEC Form D filings
- Jonathan N. CheethamExecutive OfficerNamed in SEC Form D filings
- Paul A GardnerExecutive OfficerNamed in SEC Form D filings
- Peter N. DeComoDirectorNamed in SEC Form D filings
Show all 7 people
- William A SekkelDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 11- PendingNeurorrhaphy Systems, Devices, And MethodsUSPTOApplication 18722959
- PendingNerve Graft Systems, Devices, And MethodsUSPTOApplication 18688400
- GrantedExtracellular Matrix Systems, Devices, And Methods Of DeploymentUSPTOUS 12,364,790
Show all 11 patent records
- Neurorrhaphy Systems, Devices, And MethodsNov 13, 2025 · Application 18722959Pending
- Nerve Graft Systems, Devices, And MethodsOct 9, 2025 · Application 18688400Pending
- Extracellular Matrix Systems, Devices, And Methods Of DeploymentJul 22, 2025 · US 12,364,790Granted
- Extracellular Matrix Devices And Methods Of ManufactureOct 13, 2022 · Application 17762858Pending
- Extracellular Matrix Systems, Devices, And Methods Of DeploymentApplication PCTUS2020067431Pending
- Extracellular Matrix Devices And Methods Of ManufactureApplication PCTUS2020053570Pending
- Nerve Graft Systems, Devices, And MethodsApplication PCTUS2024061633Pending
- Nerve Graft Systems, Devices, And MethodsApplication 19600891Pending
- Nerve Grafts Systems, Devices, And MethodsApplication 63615047Pending
- Neurorrhaphy Systems, Devices, And MethodsApplication PCTUS2022054351Pending
- Nerve Graft Systems, Devices, And MethodsApplication PCTUS2022045365Pending
Related companies, and why
- Co-Diagnostics, Inc.Similar federal contract value in Medtech · null in contracts
- AYUDA MEDICALSimilar federal contract value in Medtech · null in contracts
- RheoTek Medical LLCSimilar federal contract value in Medtech · null in contracts
- KDx Diagnostics, Inc.Similar federal contract value in Medtech · null in contracts
- PONS INCORPORATEDSimilar federal contract value in Medtech · null in contracts
- INCIPIAN LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .